Biotelemetry (BEAT)

Download button icon Download

Biotelemetry (BEAT): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY

[Weak Trend]: ADX for BEAT has confirmed a weak trend is presentBiotelemetry has an ATR(14) of 2.286, a DX of 6.11 & an ADX(14) of 23.11



The Average Directional Index (ADX) Minus Directional Indicator (-DI) and Plus Directional Indicator (+DI) represent a group of directional movement indicators that form a trading system developed by Welles Wilder.

Calculation: Average Directional Movement Index (ADX):
Trend Strength ;
1) 0-25 = Absent or Weak Trend;
2) 25-50 = Strong Trend;
3) 50-75 = Very Strong Trend;
4) 75-100 Extremely Strong Trend;


PROFILE: Biotelemetry (BEAT)


Stock Exchange: NASDAQ
Company: Biotelemetry
Ticker Codes: | BEAT | NASDAQ:BEAT |

About Biotelemetry (NASDAQ:BEAT):

BioTelemetry, Inc., a mobile and wireless medical technology company, provides cardiac and mobile blood glucose monitoring (BGM), centralized medical imaging, and original equipment manufacturing services for the healthcare and clinical research industries. It operates in three segments: Healthcare, Research, and Technology. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry service; and event monitoring services to prescribe wireless event, digital loop event, memory loop event, and non-loop event monitors. It also provides Holter and extended-wear Holter monitors, and pacemaker and international normalized ratio monitoring services to cardiologists and electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, including cardiac monitoring, imaging, scientific consulting, and data management services for drug, medical treatment, and device trials to pharmaceutical companies and contract research organizations. This segment's centralized services comprise ECG, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Technology segment focuses on the manufacture, engineering, and development of non-invasive cardiac monitors for healthcare companies, clinics, and hospitals worldwide. This segment offers various devices that include event monitors, digital Holter monitors, and mobile cardiac telemetry monitors, as well as a wireless BGM system. BioTelemetry, Inc. is headquartered in Malvern, Pennsylvania.

Top 10:

Average Directional Index

Download button icon Download
Company Close Change (%) Volume Value Signal
CRBP Corbus Pharma 7.95 52.9 17,857,134 21.29 BULLISH
MDXG Mimedx Inc 6.2 12.7 5,294,913 26.75 BULLISH
BLDP Ballard Power Systems 4.55 9.1 3,227,286 32.36 BULLISH
BCOM B Communications 10.5 9 1,699 22.17 BULLISH
ACHN Achillion Pharmaceuticals 3.53 8.3 1,234,050 29.18 BULLISH
CARA Cara Therapeutics 23.91 8 1,552,663 28.1 BULLISH
RARX Ra Pharmaceuticals Inc 15.58 7.8 231,906 33.21 BULLISH
RETA Reata Pharmaceuticals 91.75 7.3 312,035 34.69 BULLISH
MDCA Mdc Partners 4.6 7 1,096,476 30.7 BULLISH
INSM Insmed Inc 21.73 7 1,100,889 21.47 BULLISH
back to top